Additional Executive Hires to Support Safe, Responsible Scaling of Generative AI Healthcare Agents

Hippocratic AI, a global leader and pioneer of generative AI healthcare agents, today announced several strategic executive appointments as the company continues to scale its platform across providers, payors, and life sciences organizations. The additions strengthen Hippocratic AI’s clinical leadership, operational depth, and go-to-market execution as demand accelerates. The appointments follow Hippocratic AI’s $141 million Series C financing announced in November.

“As Hippocratic AI scales, building a leadership team grounded in clinical credibility, operational rigor, and patient safety is non-negotiable,” said Munjal Shah, CEO of Hippocratic AI. “These leaders bring decades of experience across healthcare, AI, and enterprise execution, and they will play a critical role in helping us continue to scale implementation of generative AI healthcare agents responsibly, at scale, and in service of healthcare abundance.”

New Executive Appointments:

• Dr. Anoop Sangha, MD, Associate Chief Medical Officer
  Anoop brings more than two decades of clinical practice and physician leadership experience across digital health, payor, and provider organizations. He has held senior clinical leadership roles at Transcarent, Livongo (Teladoc Health), Optum, and the Advisory Board Company, where he helped scale AI-enabled care models, remote patient monitoring, and clinical programs spanning navigation, chronic care, and population health. Dr. Sangha is board-certified in Emergency Medicine and is known for bridging clinical rigor with product, operational, and commercial strategy to drive measurable impact.
• Dr. Eduardo Reis, MD, Vice President, Strategy (Office of the CEO)
  Eduardo Pontes Reis, MD has joined Hippocratic AI as part of the Office of the CEO, bringing deep expertise at the intersection of clinical medicine, medical imaging, and artificial intelligence. A neuroradiologist and AI researcher, he has held leadership and research roles at Stanford’s Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Hospital Israelita Albert Einstein, where he has focused on building, evaluating, and deploying AI systems for real-world clinical use. Recently he has served as Founding Radiologist at a fast-growing radiology AI startup, acquired by a large radiology group. Dr. Reis brings a strong track record in medical AI to support Hippocratic AI’s executive strategy and product development.
• Niloy Sanyal, Chief Marketing Officer
  Niloy brings over 20 years of experience building and scaling healthcare, AI, and enterprise SaaS companies, with a track record of shaping category-defining brands and driving sustained growth in highly regulated markets. He has held senior leadership roles at LeanTaaS, Omnicell, and GE Digital, where he led global marketing and go-to-market functions, launched enterprise platforms, and partnered closely with product and sales teams to accelerate adoption across health systems and life sciences organizations. Across these roles, Niloy is known for translating complex technologies into clear value propositions, building high-performing teams, and establishing durable market leadership.

These appointments reinforce Hippocratic AI’s commitment to building safe generative AI healthcare agents that improve access and health outcomes as the company continues to scale.

The post Hippocratic AI Appoints New Key Execs to Further Accelerate Growth first appeared on AI-Tech Park.

Origianl Creator: Business Wire
Original Link: https://ai-techpark.com/hippocratic-ai-appoints-new-key-execs-to-further-accelerate-growth/
Originally Posted: Fri, 13 Feb 2026 12:30:00 +0000